Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
Digital platform records over 1.34 crore beneficiary registrations with QR-enabled MCH cards and real-time monitoring features
NEJM study shows strong protection across strains
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
Subscribe To Our Newsletter & Stay Updated